Multiple Sclerosis Clinical Trials in New York

Showing 561-580 of 812 trials

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

NCT02665221

The primary purpose of this single center, randomized, open label study in relapsing Multiple Sclerosis (MS) patients on PLEGRIDY (peginterferon beta-1a) is to assess the effect of Preparation H (phenylephrine) Maximum Strength Cream compared to no topical treatment of injection site erythema after PLEGRIDY injection.

Multiple Sclerosis

NYU Langone Health30 participantsStarted Jul 2015

New York, New York, United States

COMPLETEDNA< 1 mile

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

NCT00435942

The purpose of this study is to evaluate the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy will be evaluated by the device-related adverse event rate of endovascular repair (via Relay Thoracic Stent-Graft) through 1-year. Safety will be evaluated by comparing major adverse events through 1-year in subjects treated with the Relay Thoracic Stent-Graft to those who underwent surgical repair. Long term follow-up is conducted through 5 years.

Thoracic Aortic Aneurysmsand Penetrating Atherosclerotic Ulcers

Bolton Medical180 participantsStarted Jan 2007

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Francisco, California, United States +24 more locations

Single Center, Open Label, Study of Preparation H on Erythema in Relapsing MS Patients Treated With PLEGRIDY

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

Multiple Sclerosis Trials in Other Cities

Zenith® Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Continued Access Study

Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer

A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer

Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)

TR(ACE) Assay Clinical Specimen Study

LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based Chemotherapy

Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis

Study To Examine The Effects Of Lapatinib On The Pharmacokinetics Of Digoxin In Subjects w/ ErbB2 Positive Breast Cancer

A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Participants

Other Conditions in New York